Rubin leaving Boundless as CFO, new CSOs for C4, Avacta and Commit 

Boundless Bio Inc. (NASDAQ:BOLD) announced the departure of CFO Jami Rubin, who is leaving the San Diego-based biotech for personal reasons. Boundless named SVP Finance and Controller David Hinkle principal financial and accounting officer and said the company does not plan to hire a new CFO. Rubin joined Boundless in July 2023 and took the company public this year, shortly before it announced plans to extend its operating runway by scaling back early discovery work.

Three companies hired new CSOs. Paige Mahaney will become CSO of  C4 Therapeutics Inc. (NASDAQ:CCCC) on Oct. 28, succeeding Stewart Fisher, who is retiring. Mahaney was SVP and corporate head of drug discovery at Exelixis Inc. (NASDAQ:EXEL)...